Anderhalden R T, Tschanz H U, Streuli R
Medizinische Klinik, Regionalspital Langenthal.
Schweiz Med Wochenschr. 1992 Jan 18;122(3):60-5.
From January 1, 1989 to September 30, 1990, 116 patients with acute myocardial infarction were hospitalized at the regional hospital of Langenthal. Of those 116 patients, 27 (23%) were treated with intravenous streptokinase; in 12 of them (44%) CPK reached its peak within 6 hours after starting lysis; all were admitted within 4 hours after the beginning of chest pain. Of the fibrinolyzed patients, 18 (67%) had arrhythmias which needed to be treated. In 10 of these 18 patients CPK reached its peak within 6 hours. Of the 89 patients not treated with streptokinase, 27 (30%) did not fulfill the entry criteria of the protocol, 16 (18%) had exclusion criteria, and 46 (52%) had exclusion criteria as well as absent inclusion criteria. In only 4 patients (4.5%) was lysis not possible because they entered hospital later than 6 hours after the beginning of pain, and 8 patients (9%) exceeded the upper age limit of 70 years. Of the 116 patients, 13 (11.2%) died; 12 were not treated with streptokinase. Our study shows that fibrinolytic treatment with streptokinase is a safe and effective therapy for patients with acute myocardial infarction and can easily be performed in a regional hospital.
1989年1月1日至1990年9月30日期间,116例急性心肌梗死患者在朗根塔尔地区医院住院。在这116例患者中,27例(23%)接受了静脉注射链激酶治疗;其中12例(44%)的肌酸磷酸激酶(CPK)在开始溶栓后6小时内达到峰值;所有患者均在胸痛开始后4小时内入院。在接受溶栓治疗的患者中,18例(67%)出现需要治疗的心律失常。在这18例患者中的10例中,CPK在6小时内达到峰值。在89例未接受链激酶治疗的患者中,27例(30%)不符合方案的入选标准,16例(18%)有排除标准,46例(52%)既有排除标准又无入选标准。只有4例患者(4.5%)因在疼痛开始后6小时后才入院而无法进行溶栓,8例患者(9%)超过了70岁的年龄上限。在这116例患者中,13例(11.2%)死亡;12例未接受链激酶治疗。我们的研究表明,链激酶溶栓治疗对急性心肌梗死患者是一种安全有效的治疗方法,并且可以在地区医院轻松实施。